Skip to content

Partner with us

Drug discovery icon

Access novel targets with extensive data packages, matched to patients with unmet medical needs 

Biological pathways icon

Understand the link between dysregulated biological pathways and multiple disease indications

Select patients for clinical trials icon

License biomarkers to select patients for clinical trials, and support product launch and market adoption

Translational discovery advantage

Our high-resolution patient stratification reveals previously unrecognized disease mechanisms which bring with them new targets for drug discovery and opportunities for first-in-class medicines.

View our pipeline
Biomarker-driven discovery-min

Biomarker-driven discovery

Our patient stratification provides biomarkers for the selection of highly relevant translational disease models, in patient selection for clinical trials, and in the design of companion diagnostics.

The right targets with the right efficacy

To ensure the right targets are selected, we apply proven drug discovery evaluation frameworks, such as the 5Rs criteria for small molecules and extend them to include the selection of targets with the right efficacy potential to minimize late-stage failure risks in downstream clinical trials.

Selecting the right targets with the right efficacy-min

Benefits of our unique approach

Our approach enables a precision medicine in complex chronic diseases – uniquely matching targets to the patient sub-populations that are most likely to benefit.

We integrate all forms of large datasets to rapidly provide links to new areas of biology and potential new therapeutic targets.

And our mechanistic patient stratification biomarkers accurately match new therapies to responders in downstream clinical trials and the clinic.

Learn more about our approach

Gain translational discovery advantage

Select and in-license the right targets for drug discovery based on deep understanding of the disease biology across your patient population.

Contact us